Financials

  • Market Capitalization 36.3476 M
  • Employee 89
  • Founded 2012
  • CEO N/A
  • Website www.omniab.com
  • Headquarter Delaware, United States
  • FIGI BBG012QXTPF0
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.21
ratio cours/chiffre d'affaires
0.24

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4356
ALGS
Aligos Therapeutics, Inc. - Common stock
6.09 USD+3.92%-17.37%+41.96%-37.79%37.98 M USD
4366
ACTU
Actuate Therapeutics, Inc. - Common stock
1.54 USD+1.32%-10.98%+35.09%-62.25%36.98 M USD
4387
RNAZ
TransCode Therapeutics, Inc. - Common Stock
2.06 USD-1.90%-20.16%-54.42%-78.33%34.88 M USD
4398
LITS
Lite Strategy, Inc. - Common Stock
0.99 USD0.00%-5.71%+2.06%-66.78%33.68 M USD

Nouvelles